Cynthia A. Flanders's most recent trade in Argan, Inc. was a trade of 530 Time-Based Restricted Stock Units done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Argan, Inc. | Cynthia A. Flanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 530 | 3,947 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | Cynthia A. Flanders | Director | Sale of securities on an exchange or to another person at price $ 220.47 per share. | 12 Jun 2025 | 15,000 | 33,428 (0%) | 0% | 220.5 | 3,307,050 | Common Stock |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 10,000 | 61,500 | - | - | Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 10,000 | 51,500 | - | - | Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 10,000 | 31,500 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 10,000 | 41,500 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.44 per share. | 09 Jun 2025 | 8,749 | 24,581 (0%) | 0% | 30.4 | 266,320 | Common Stock |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.19 per share. | 09 Jun 2025 | 8,308 | 48,038 (0%) | 0% | 41.2 | 342,207 | Common Stock |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 46.35 per share. | 09 Jun 2025 | 8,096 | 39,730 (0%) | 0% | 46.4 | 375,250 | Common Stock |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.75 per share. | 09 Jun 2025 | 7,053 | 31,634 (0%) | 0% | 71.8 | 506,053 | Common Stock |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 390 | 48,428 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2025 | 388 | 3,417 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | Cynthia A. Flanders | Director | Sale of securities on an exchange or to another person at price $ 133.64 per share. | 02 Apr 2025 | 4,092 | 15,832 (0%) | 0% | 133.6 | 546,855 | Common Stock |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 1,757 | 19,089 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 1,750 | 4,638 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 835 | 19,924 (0%) | 0% | 0 | Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 833 | 3,805 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | Cynthia A. Flanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2024 | 388 | 6,388 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | Cynthia A. Flanders | Director | Sale of securities on an exchange or to another person at price $ 96.39 per share. | 25 Sep 2024 | 5,000 | 17,332 (0%) | 0% | 96.4 | 481,944 | Common Stock |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2024 | 10,000 | 71,500 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.82 per share. | 17 Jun 2024 | 5,832 | 22,332 (0%) | 0% | 31.8 | 185,574 | Common Stock |
| Argan, Inc. | A. Flanders Cynthia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 2,500 | 6,000 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | Cynthia A. Flanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 1,500 | 81,500 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 05 Oct 2023 | 7,000 | 15,000 (0%) | 0% | 46 | 322,000 | Common Stock |
| Argan, Inc. | Cynthia A. Flanders | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2023 | 7,000 | 80,000 | - | - | Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Purchase of securities on an exchange or from another person at price $ 26.88 per share. | 05 Oct 2023 | 7,000 | 22,000 (0%) | 0% | 26.9 | 188,160 | Common Stock |
| Argan, Inc. | Cynthia A. Flanders | Director | Purchase of securities on an exchange or from another person at price $ 46.53 per share. | 05 Oct 2023 | 1,500 | 16,500 (0%) | 0% | 46.5 | 69,795 | Common Stock |
| Argan, Inc. | Cynthia A. Flanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 5,000 | 87,000 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 1,750 | 3,500 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | Cynthia A. Flanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 5,000 | 82,000 | - | - | Option to Purchase Common Stock | |
| Argan, Inc. | Cynthia A. Flanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 1,750 | 1,750 | - | - | Time-Based Restricted Stock Units | |
| Argan, Inc. | Cynthia A. Flanders | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2020 | 10,000 | 77,000 | - | - | Stock Option to Purchase |